Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection

1 Oct 2024

Abstract excerpt

Nucleoside-modified mRNA-LNP vaccines have revolutionized vaccine development against infectious pathogens due to their ability to elicit potent humoral and cellular immune responses. In this article, we present the results of the first norovirus vaccine candidate employing mRNA-LNP platform technology. The mRNA-LNP bivalent vaccine encoding the major capsid protein VP1 from GI.1 and GII.4 of human norovirus,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Viral gastroenteritis research and epidemiology
Share to Viral Infections and Immunology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39353926
DOI: 10.1038/s41541-024-00976-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infectionPMID 39353926Read ↗

Chimeric GII.4 Norovirus Virus-Like-Particle-Based Vaccines Induce Broadly Blocking Immune ResponsesSemantic proximity Read ↗

Epidemiology of human noroviruses and updates on vaccine development.Semantic proximity Read ↗

Development of a broad-spectrum therapeutic Fc-nanobody for human norovirusesSemantic proximity Read ↗

Efficacy of an intramuscular bivalent norovirus GI.1/GII.4 virus-like particle vaccine candidate in healthy US adults.Semantic proximity Read ↗

Vaccine against norovirus.Semantic proximity Read ↗

Recent advances in human norovirus research and implications for candidate vaccines.Semantic proximity Read ↗

A quadrivalent norovirus vaccine based on a chimpanzee adenovirus vector induces potent immunity in mice.Semantic proximity Read ↗

Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseasesSemantic proximity Read ↗

An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infectionSemantic proximity Read ↗

Integrated in-silico design and in vivo validation of multi-epitope vaccines for norovirusSemantic proximity Read ↗

A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccineSemantic proximity Read ↗

An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.